Global Hemostats Market, By
Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose
Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure,
Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community
Healthcare, Others), By Geography (North America, South America, Europe,
Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024
The global
hemostats market has accounted to USD 2.7 billion in 2016, and is expected
to reach USD 4.5 billion by 2024, growing at a CAGR of 6.5% in the forecast
period 2017 to 2024.
Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample?dbmr=global-hemostats-market-trends-forecast-2024
The global hemostats
market is segmented into based on product type, indication, end-user and geography.
On the
basis of product types the global hemostats market is segmented into 5 product
type’s thrombin based hemostats, combination agents hemostats, oxidized
regeneration cellulose based hemostats, gelatin based hemostats and collagen
based segments. The market report covers market value and volume of the
segments mentioned earlier. In 2015, in terms of market value the thrombin
based hemostats market segment dominates the market with 34.1% market share.
While the combination based hemostats market is expected to grow at the highest
CAGR in the forecast period of 2016 to 2022. In terms of volume the hemostats
market is dominated by thrombin based hemostats with 41.7% market share in
2015.
The global
hemostats market is further segmented based on indications into wound
closure and surgery. The surgery segment dominates the market in 2015.
The global
hemostats market is further segmented on the basis of end users into hospitals,
clinics, ambulatory centers, community healthcare and others.
Inquiry
before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying?dbmr=global-hemostats-market-trends-forecast-2024
The global hemostats market report contains an
in-depth profiling of the key market players, along with the recent
developments (New product launches, partnerships, agreements, collaborations,
and joint ventures) and strategies adopted by them to sustain and strengthen
their positions in the market. Some of the recent developments in the hemostats
market are: April 2015, Ethicon’s fibrin sealant patch received food and drug
administration approval for extended surgical indications; April 2016, 3-D
Matrix Europe subsidiary entered partnership with Chile based M. Kaplan Y CIA
LTDA. for sistribution rights of PuraStat hemostat of 3-D Matrix in Chile. The
global hemostats market report also contains market share by manufacturer’s
data for U.S., Canada, Brazil, Mexico, Germany, France, U.K., China, India,
Japan, North America, South America, Europe, Asia-Pacific and Middle East and
Africa.
Based on geography the Global Hemostats Market is segmented
into:
·
North America
·
South America
·
Europe
·
Asia-Pacific
·
Middle East and Africa
Browse Full Report Visit @ http://databridgemarketresearch.com/reports/medical-devices/general-surgery-medical-devices/global-hemostats-market-trends-forecast-2024
Some of the major companies operating in this market are:
·
Pfizer
·
C.R. Bard
·
Baxter
·
Vascular Solutions, Inc.
·
B.Braun Melsungen
·
3-D Matrix, Ltd.
·
Resorba Medical GmbH (A Advanced Medical Solutions Group plc
Company)
·
Anika Therapeutics, Inc.
·
Arch Therapeutics Inc.
·
Biom’Up SAS
·
CryoLife, Inc.
·
Gamma Therapeutics, Inc.
·
Hemostasis, LLC
·
Medtrade Products Ltd.
·
Integra Lifesciences Corporation
·
Medline Industries, Inc.
·
Hemotec Medical GmbH
·
Stryker
·
Hemostasis
·
LLC.
·
CSL Behring
·
Mallinckrodt plc.
·
Equimedical, B.V.
Table
of Content:
1.
INTRODUCTION
1.1. OVERVIEW OF THE HEMOSTATS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
2.
RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL HEMOSTATS
MARKET
2.3. GLOBAL HEMOSTATS MARKET: RESEARCH
SNAPSHOT
2.4. ASSUMPTIONS
3.
MARKET LANDSCAPE SUMMARY
4.
PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL HEMOSTATS MARKET: KEY PRIMARY
INSIGHTS
4.3. MARKET OVERVIEW
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5.
HEMOSTATS MARKET, BY PRODUCT TYPE
6.
HEMOSTATS MARKET, BY INDICATION
7.
HEMOSTATS MARKET, BY END-USER
8.
HEMOSTATS MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE HEMOSTATS MARKET, (ALL
SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
8.1.1. NORTH AMERICA
8.1.2. EUROPE
8.1.3.
ASIA-PACIFIC (APAC)
8.1.4. LATIN AMERICA
8.1.5. MIDDLE EAST AND AFRICA
8.2. KEY PRIMARY INSIGHTS: BY MAJOR
COUNTRIES
9.
HEMOSTATS MARKET: COMPETITIVE LANDSCAPE
9.1. GLOBAL HEMOSTATS MARKET: COMPANY
SHARE ANALYSIS
9.2. U.S. HEMOSTATS MARKET: COMPANY SHARE
ANALYSIS
9.3. EUROPE HEMOSTATS MARKET: COMPANY
SHARE ANALYSIS
9.4. ASIA-PACIFIC HEMOSTATS MARKET:
COMPANY SHARE ANALYSIS
9.5. MERGERS & ACQUISITIONS
9.6. NEW PRODUCT DEVELOPMENT &
APPROVALS
9.7. EXPANSIONS
9.8. REGULATORY CHANGES
9.9. PARTNERSHIP AND OTHER STRATEGIC
DEVELOPMENTS
10.
HEMOSTATS MARKET, COMPANY PROFILES
10.1. ETHICON, INC. (A JOHNSON AND
JOHNSON COMPANY)
10.2. PFIZER
10.3. C.R. BARD
10.4. BAXTER
10.5. VASCULAR SOLUTIONS, INC.
10.6. B.BRAUN MELSUNGEN
10.7. 3-D MATRIX, LTD
10.8. RESORBA MEDICAL GMBH (A ADVANCED
MEDICAL SOLUTIONS GROUP PLC COMPANY)
10.9. ANIKA THERAPEUTICS, INC.
10.10. ARCH THERAPEUTICS INC.
10.11. BIOM’UP SAS
10.12. CRYOLIFE, INC.
10.13. GAMMA THERAPEUTICS, INC.
10.14. HEMOSTASIS, LLC
10.15. MEDTRADE PRODUCTS LTD.
10.16. INTEGRA LIFESCIENCES CORPORATION
10.17. MEDLINE INDUSTRIES, INC.
10.18. HEMOTEC MEDICAL GMBH
10.18.1. OVERVIEW
10.18.2. SWOT ANALYSIS
10.18.3. PRODUCT PORTFOLIO
10.18.4. REVENUE ANALYSIS
10.18.5. ANALYSTS VIEW
10.19. STRYKER
10.19.1. OVERVIEW
10.19.2. SWOT ANALYSIS
10.19.3. PRODUCT PORTFOLIO
10.19.4. REVENUE ANALYSIS
10.19.5. ANALYSTS VIEW
10.20. HEMOSTASIS, LLC.
10.20.1. OVERVIEW
10.20.2. SWOT ANALYSIS
10.20.3. PRODUCT PORTFOLIO
10.20.4. REVENUE ANALYSIS
10.20.5. ANALYSTS VIEW
10.21. CSL BEHRING
10.21.1. OVERVIEW
10.21.2. SWOT ANALYSIS
10.21.3. PRODUCT PORTFOLIO
10.21.4. REVENUE ANALYSIS
10.21.5. ANALYSTS VIEW
10.22. MALLINCKRODT PLC.
10.22.1. OVERVIEW
10.22.2. SWOT ANALYSIS
10.22.3. PRODUCT PORTFOLIO
10.22.4. REVENUE ANALYSIS
10.22.5. ANALYSTS VIEW
10.23. EQUIMEDICAL, B.V.
10.23.1. OVERVIEW
10.23.2. SWOT ANALYSIS
10.23.3. PRODUCT PORTFOLIO
10.23.4. REVENUE ANALYSIS
10.23.5. ANALYSTS VIEW
Related
Report
Global
Medical Instruments Disinfections Market – Trends and Forecast to 2024
Global Medical Instruments Disinfection
Market, By Product Type (Disinfectants (Wipes, Sprays, Liquid), Disinfectors,
Endoscopic Reprocessors), End-Users, By Distribution Channel, By Geography
(North America, Europe, Asia-Pacific, South America and Middle East and Africa)
– Trends and Forecast to 2024
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric Market
research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Ankit Singh
Data Bridge
Market Research
Tel:
+1-888-387-2818
Investor: investors@databridgemarketresearch.com
Follow
us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research